サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1239513

組織拡張器市場：病変部位別（下肢、上肢、その他）、製品形状別（長方形、三日月、円形、その他）、エンドユーザー別（病院、美容クリニック、その他）、世界の機会分析および産業予測、2021年～2031年

Tissue Expanders Market By Lesion Site (Lower Extremity, Upper Extremity, Others), By Product Shape (Rectangular, Crescent, Round, Others), By End User (Hospitals, Cosmetic Clinics, Others): Global Opportunity Analysis & Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 397 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
組織拡張器市場：病変部位別（下肢、上肢、その他）、製品形状別（長方形、三日月、円形、その他）、エンドユーザー別（病院、美容クリニック、その他）、世界の機会分析および産業予測、2021年～2031年
出版日: 2023年01月01日
発行: Allied Market Research
ページ情報: 英文 397 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組織拡張器の世界市場規模は、2021年に6億7,150万米ドルで、2022年から2031年にかけて5.8%のCAGRを示し、2031年には11億8,000万米ドルに達すると予測されています。

組織拡張器は、シリコンと充填剤成分でできたバルーンで、あらかじめ形の整ったプロテーゼに成形され、エキスパンダーの表面に組み込まれたバルブシステム（初期のエキスパンダーはこの構造でしたが、現在では見られません）、またはエキスパンダーに柔軟なシラスティック充填チューブで接続されているリモートバルブ（現在ではほぼすべてのエキスパンダーがリモートバルブを備えています）を通じて生理食塩水を充填することができます。遠隔バルブと充填チューブの主な利点は、注入箇所をバルーンから遠ざけることで、エキスパンダーの膨張中にバルーンを穿刺する危険性を排除することです。また、遠隔位置決めにより、皮膚の下の容易に感じることができる場所に設置することができます。

組織拡張器市場の成長は、さまざまな組織拡張器の開拓のための技術的進歩や乳がんの有病率の上昇によってもたらされます。また、市場の主要プレーヤーによる製品発売や製品承認などのさまざまな戦略の増加が、市場の成長を促進すると予想されます。乳がんは女性に最も多いタイプのがんであり、悪性細胞を除去するために乳房切除術が必要となるため、乳房再建のための四肢組織拡張器の使用が増加することになっています。このように、乳がんを患う女性患者の増加は、組織拡張器の需要を促進し、市場成長を促進すると予想されます。

美的外観を改善するための低侵襲処置の採用の増加は、組織拡張器の需要を促進し、市場成長を後押しすると予想されます。例えば、国際美容整形学会によると、2020年には、世界中の整形外科医によって約10,129,528件の美容整形手術が実施されたと報告されています。組織拡張器は、頭皮の再建、乳房の再建、口腔・顎顔面の再建、火傷の傷跡の修復に使用されています。このように、火傷や口腔・顎顔面変形症の増加は、組織拡張器の需要の急増につながっています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威が高い
    • 新規参入業者の脅威が高い
    • ライバル意識の高さ
  • 市場力学
    • 促進要因
      • 低侵襲手術の増加
      • 乳がんの有病率の上昇
      • 美容整形に対する意識の高まり
    • 抑制要因
      • 再建手術の副作用
    • 機会
      • 主要戦略の採用数の増加：市場関係者別
  • 市場におけるCOVID-19影響分析

第4章 組織拡張器市場：病変部位別

  • 概要
    • 市場規模と予測
  • 下肢
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 上端部
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
    • その他の組織拡張器市場：アプリケーション別
      • 乳房再建の市場規模と予測：地域別
      • 顔面再建の市場規模と予測：地域別
      • その他市場規模と予測：地域別

第5章 組織拡張器市場：製品形状別

  • 概要
    • 市場規模と予測
  • 長方形
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • クレセント
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • ラウンド
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第6章 組織拡張器市場：エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 美容クリニック
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第7章 組織拡張器市場：地域別

  • 概要
    • 市場規模と予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測：部位別
      • 北米その他の組織拡張器市場：用途別
    • 市場規模と予測：製品形状別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測：部位別
      • 欧州その他の組織拡張器市場：アプリケーション別
    • 市場規模と予測：製品形状別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測：部位別
      • アジア太平洋その他の組織拡張器市場：アプリケーション別
    • 市場規模と予測：製品形状別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測：部位別
      • LAMEAその他の組織拡張器市場：アプリケーション別
    • 市場規模と予測：製品形状別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別
      • ラテンアメリカ・中東・アフリカの残り
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：部位別
      • 市場規模と予測：製品形状別
      • 市場規模と予測：エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第9章 企業プロファイル

  • GC Aesthetics PLC
  • Abbvie Inc
  • Guangzhou Wanhe Plastic Materials Co. Ltd
  • Johnson & Johnson
  • Groupe Sebbin SAS
  • Sientra, Inc.
  • PMT Corporation
  • Establishment Labs
  • Silimed
  • POLYTECH Health & Aesthetics GmbH
図表

LIST OF TABLES

  • TABLE 01. GLOBAL TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. TISSUE EXPANDERS MARKET FOR LOWER EXTREMITY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. TISSUE EXPANDERS MARKET FOR UPPER EXTREMITY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. GLOBAL OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. TISSUE EXPANDERS MARKET FOR BREAST RECONSTRUCTION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. TISSUE EXPANDERS MARKET FOR FACIAL RECONSTRUCTION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. GLOBAL TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. TISSUE EXPANDERS MARKET FOR RECTANGULAR, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. TISSUE EXPANDERS MARKET FOR CRESCENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. TISSUE EXPANDERS MARKET FOR ROUND, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. GLOBAL TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. TISSUE EXPANDERS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. TISSUE EXPANDERS MARKET FOR COSMETIC CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. TISSUE EXPANDERS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. NORTH AMERICA OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. NORTH AMERICA TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. U.S. TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. U.S. TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. CANADA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. MEXICO TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. EUROPE TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ITALY TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SPAIN TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SPAIN TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF EUROPE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. REST OF EUROPE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. JAPAN TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. JAPAN TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. JAPAN TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. CHINA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. CHINA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. CHINA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. INDIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. INDIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. AUSTRALIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. AUSTRALIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. AUSTRALIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. SOUTH KOREA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. SOUTH KOREA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. SOUTH KOREA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. LAMEA OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. LAMEA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. LAMEA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. LAMEA TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. BRAZIL TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. BRAZIL TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. BRAZIL TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. REST OF LAMEA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. REST OF LAMEA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. REST OF LAMEA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. GC AESTHETICS PLC: KEY EXECUTIVES
  • TABLE 97. GC AESTHETICS PLC: COMPANY SNAPSHOT
  • TABLE 98. GC AESTHETICS PLC: PRODUCT SEGMENTS
  • TABLE 99. GC AESTHETICS PLC: PRODUCT PORTFOLIO
  • TABLE 100. ABBVIE INC: KEY EXECUTIVES
  • TABLE 101. ABBVIE INC: COMPANY SNAPSHOT
  • TABLE 102. ABBVIE INC: PRODUCT SEGMENTS
  • TABLE 103. ABBVIE INC: PRODUCT PORTFOLIO
  • TABLE 104. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: KEY EXECUTIVES
  • TABLE 105. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: COMPANY SNAPSHOT
  • TABLE 106. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: PRODUCT SEGMENTS
  • TABLE 107. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: PRODUCT PORTFOLIO
  • TABLE 108. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 109. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 110. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 111. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 112. GROUPE SEBBIN SAS: KEY EXECUTIVES
  • TABLE 113. GROUPE SEBBIN SAS: COMPANY SNAPSHOT
  • TABLE 114. GROUPE SEBBIN SAS: PRODUCT SEGMENTS
  • TABLE 115. GROUPE SEBBIN SAS: PRODUCT PORTFOLIO
  • TABLE 116. SIENTRA, INC.: KEY EXECUTIVES
  • TABLE 117. SIENTRA, INC.: COMPANY SNAPSHOT
  • TABLE 118. SIENTRA, INC.: PRODUCT SEGMENTS
  • TABLE 119. SIENTRA, INC.: PRODUCT PORTFOLIO
  • TABLE 120. PMT CORPORATION: KEY EXECUTIVES
  • TABLE 121. PMT CORPORATION: COMPANY SNAPSHOT
  • TABLE 122. PMT CORPORATION: PRODUCT SEGMENTS
  • TABLE 123. PMT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 124. ESTABLISHMENT LABS: KEY EXECUTIVES
  • TABLE 125. ESTABLISHMENT LABS: COMPANY SNAPSHOT
  • TABLE 126. ESTABLISHMENT LABS: PRODUCT SEGMENTS
  • TABLE 127. ESTABLISHMENT LABS: PRODUCT PORTFOLIO
  • TABLE 128. ESTABLISHMENT LABS: KEY STRATERGIES
  • TABLE 129. SILIMED: KEY EXECUTIVES
  • TABLE 130. SILIMED: COMPANY SNAPSHOT
  • TABLE 131. SILIMED: PRODUCT SEGMENTS
  • TABLE 132. SILIMED: PRODUCT PORTFOLIO
  • TABLE 133. POLYTECH HEALTH & AESTHETICS GMBH: KEY EXECUTIVES
  • TABLE 134. POLYTECH HEALTH & AESTHETICS GMBH: COMPANY SNAPSHOT
  • TABLE 135. POLYTECH HEALTH & AESTHETICS GMBH: PRODUCT SEGMENTS
  • TABLE 136. POLYTECH HEALTH & AESTHETICS GMBH: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. TISSUE EXPANDERS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF TISSUE EXPANDERS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN TISSUE EXPANDERS MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALTISSUE EXPANDERS MARKET
  • FIGURE 10. TISSUE EXPANDERS MARKET, BY LESION SITE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR LOWER EXTREMITY, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR UPPER EXTREMITY, BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 14. TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR RECTANGULAR, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR CRESCENT, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR ROUND, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. TISSUE EXPANDERS MARKET, BY END USER, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR COSMETIC CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. TISSUE EXPANDERS MARKET BY REGION, 2021
  • FIGURE 24. U.S. TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. CANADA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. MEXICO TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. GERMANY TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. FRANCE TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. UK TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. ITALY TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. SPAIN TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. REST OF EUROPE TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. JAPAN TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. CHINA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. AUSTRALIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH KOREA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. BRAZIL TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SAUDI ARABIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. SOUTH AFRICA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. REST OF LAMEA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: TISSUE EXPANDERS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. ABBVIE INC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. ABBVIE INC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 52. ABBVIE INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 53. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 54. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 56. SIENTRA, INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 57. SIENTRA, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 58. SIENTRA, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 59. ESTABLISHMENT LABS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 60. ESTABLISHMENT LABS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 61. ESTABLISHMENT LABS: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A13407

The Tissue Expanders Market valued for $671.5 million in 2021 and is estimated to reach $1,180.0 million by 2031, exhibiting a CAGR of 5.8% from 2022 to 2031. Tissue expanders are balloons made of silicon and filler ingredients, molded into a pre-shaped prosthesis, which can be filled with saline through a valve system, which is either incorporated on the expander's surface (early expanders had this structure which is not seen nowadays) or is remote and connected by a flexible silastic filling tube to the expander (nearly all expanders nowadays have a remote valve). The main benefit of the remote valve and filling tube is that it keeps the injection point far from the balloon, eliminating any potential hazards of balloon puncture during expander inflation. Remote positioning enables placing at a location beneath the skin where it can be felt readily.

The growth of tissue expanders market is driven by technological advancement for development of different tissue expanders and rise in the prevalence of breast cancer. In addition, increase in number of various strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. Breast cancer is the most common type of cancer in women and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of extremity tissue expanders for breast reconstruction. Thus, rise in number of female patients suffering from breast cancer is anticipated to drive the demand for tissue expanders and fuel the market growth.

Rise in the adoption of minimally invasive procedure for improvement of aesthetic appearance is expected to drive the demand for tissue expanders and boost the market growth. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, it was reported that, approximately 10,129,528 cosmetic procedures were performed by plastic surgeons worldwide. Tissue expanders are used for scalp reconstruction, breast reconstruction, oral & maxillofacial reconstruction, and to repair burn scars. Thus, rise in number of burn injuries and oral & maxillofacial deformity lead to upsurge in demand for tissue expanders.

In addition, the Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, & security of human & veterinary drugs, biological products, and medical devices. Rise in product approval for tissue expanders by Food and Drug Administration (FDA) is anticipated to drive the growth of tissue expanders market. For instance, in October 2022, according to Food and Drug Administration, it was reported that, the FDA has cleared 48 tissue expanders and accessories.

In addition, rise in expenditure by governments to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals and clinics. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for tissue expanders for reconstructive procedures, thereby boosting the market growth.

On the other hand, high cost of treatment and side effects of the tissue expansion procedures are some factors that are anticipated to restrain the growth of the tissue expanders market.

The tissue expanders market is segmented on the basis of lesion site, product shape, application, end user, and region. By product type, the market is fragmented into lower extremity, upper extremity, and others. The others segment is further divided into trunk, back, and head. By product shape, the market is categorized into rectangular, crescent, round, and others. The others segment is further divided into anatomical, elliptical, and cylindrical. On the basis of application, the market is classified into breast reconstruction, facial reconstruction, and others. The others segment is further divided into congenital disorders, burn scar, and scalp reconstruction. By end user, the market is fragmented into hospitals, cosmetic clinics, and others. The others segment is further bifurcated into ambulatory surgical centers and burn center. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global tissue expanders market include: GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Establishment Labs, and Silimed.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tissue expanders market analysis from 2021 to 2031 to identify the prevailing tissue expanders market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the tissue expanders market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global tissue expanders market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Lesion Site

  • Lower Extremity
  • Upper Extremity
  • Others
    • Application
    • Breast reconstruction
    • Facial reconstruction
    • Others

By Product Shape

  • Rectangular
  • Crescent
  • Round
  • Others

By End User

  • Others
  • Hospitals
  • Cosmetic Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Abbvie Inc
  • Johnson & Johnson
  • Groupe Sebbin SAS
  • Sientra, Inc.
  • PMT Corporation
  • Establishment Labs
  • Silimed
  • POLYTECH Health & Aesthetics GmbH
  • Guangzhou Wanhe Plastic Materials Co. Ltd
  • GC Aesthetics PLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the number of minimally invasive surgeries.
      • 3.4.1.2. Rise in the prevalence of breast cancer.
      • 3.4.1.3. Increase in the awareness regarding cosmetic surgeries.
    • 3.4.2. Restraints
      • 3.4.2.1. Side effects of reconstructive surgery.
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of adoptions of key strategies by market players.
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: TISSUE EXPANDERS MARKET, BY LESION SITE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Lower Extremity
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Upper Extremity
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Others
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Others Tissue Expanders Market by Application
      • 4.4.4.1. Breast reconstruction Market size and forecast, by region
      • 4.4.4.2. Facial reconstruction Market size and forecast, by region
      • 4.4.4.3. Others Market size and forecast, by region

CHAPTER 5: TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Rectangular
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Crescent
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Round
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: TISSUE EXPANDERS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cosmetic Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: TISSUE EXPANDERS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Lesion Site
      • 7.2.2.1. North America Others Tissue Expanders Market by Application
    • 7.2.3. Market size and forecast, by Product Shape
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Lesion Site
      • 7.2.5.1.3. Market size and forecast, by Product Shape
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Lesion Site
      • 7.2.5.2.3. Market size and forecast, by Product Shape
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Lesion Site
      • 7.2.5.3.3. Market size and forecast, by Product Shape
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Lesion Site
      • 7.3.2.1. Europe Others Tissue Expanders Market by Application
    • 7.3.3. Market size and forecast, by Product Shape
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Lesion Site
      • 7.3.5.1.3. Market size and forecast, by Product Shape
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Lesion Site
      • 7.3.5.2.3. Market size and forecast, by Product Shape
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Lesion Site
      • 7.3.5.3.3. Market size and forecast, by Product Shape
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Lesion Site
      • 7.3.5.4.3. Market size and forecast, by Product Shape
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Lesion Site
      • 7.3.5.5.3. Market size and forecast, by Product Shape
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Lesion Site
      • 7.3.5.6.3. Market size and forecast, by Product Shape
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Lesion Site
      • 7.4.2.1. Asia-Pacific Others Tissue Expanders Market by Application
    • 7.4.3. Market size and forecast, by Product Shape
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Lesion Site
      • 7.4.5.1.3. Market size and forecast, by Product Shape
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Lesion Site
      • 7.4.5.2.3. Market size and forecast, by Product Shape
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Lesion Site
      • 7.4.5.3.3. Market size and forecast, by Product Shape
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Lesion Site
      • 7.4.5.4.3. Market size and forecast, by Product Shape
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Lesion Site
      • 7.4.5.5.3. Market size and forecast, by Product Shape
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Lesion Site
      • 7.4.5.6.3. Market size and forecast, by Product Shape
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Lesion Site
      • 7.5.2.1. LAMEA Others Tissue Expanders Market by Application
    • 7.5.3. Market size and forecast, by Product Shape
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Lesion Site
      • 7.5.5.1.3. Market size and forecast, by Product Shape
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Lesion Site
      • 7.5.5.2.3. Market size and forecast, by Product Shape
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Lesion Site
      • 7.5.5.3.3. Market size and forecast, by Product Shape
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Lesion Site
      • 7.5.5.4.3. Market size and forecast, by Product Shape
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. GC Aesthetics PLC
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Abbvie Inc
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Guangzhou Wanhe Plastic Materials Co. Ltd
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Johnson & Johnson
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Groupe Sebbin SAS
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Sientra, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. PMT Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Establishment Labs
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Silimed
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. POLYTECH Health & Aesthetics GmbH
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio